The TP - Mold Illness Panel #1 panel contains 4 tests with 5 biomarkers.
The TP - Mold Illness Panel #1 comprises a series of tests each designed to evaluate specific markers or genetic predispositions that may indicate an individual's susceptibility to mold-related illnesses. Here is a detailed description of each test within the panel and the benefits of conducting these tests:
Test Name: Alpha Melanocyte Stimulating Hormone #91898
- Description: This test measures the levels of alpha melanocyte stimulating hormone (α-MSH) in the blood, which is involved in inflammation regulation, immune response, and melanogenesis.
- Purpose: The benefit of measuring α-MSH levels is to use it as an indicator of potential mold exposure and related health conditions. Elevated α-MSH levels can signal chronic inflammatory response syndrome (CIRS) and mold illness, aiding in the diagnosis and management of these conditions.
Test Name: Copeptin #37740
- Description: This test assesses the concentration of copeptin in the blood, a fragment of the hormone vasopressin associated with stress responses, including those triggered by mold exposure.
- Purpose: The main benefit is evaluating copeptin levels as a marker of HPA (hypothalamic-pituitary-adrenal) axis activation, which can indicate stress-related conditions and mold illness. This helps in understanding the stress response and guiding treatment strategies.
Test Name: HLA Class II DR, DQ DNA Typing #15485
- Description: This genetic test looks at the variation in HLA class II genes DR and DQ to identify specific alleles associated with a higher risk of mold-related illnesses.
- Purpose: Identifying HLA class II genetic variants linked to susceptibility to mold-related illnesses is beneficial for determining an individual's predisposition to adverse reactions following mold exposure. This knowledge can inform personalized preventive and treatment strategies.
Test Name: HLA DRB3,4,5 Low Resolution #19526
- Description: Provides low-resolution typing of the HLA class II genes DRB3, DRB4, and DRB5, associated with immune dysregulation and increased susceptibility to mold-related illnesses.
- Purpose: The benefit of this test is in determining genetic predispositions to mold-related health conditions through low-resolution typing of specific HLA class II genes. It aids in broader genetic screening to identify those at risk, guiding more targeted investigations or interventions.
Overall Purpose of the TP - Mold Illness Panel #1
The comprehensive evaluation offered by the TP - Mold Illness Panel #1 is beneficial in multiple ways:
- Diagnostic Insight: It provides clinicians with a deeper understanding of an individual's physiological and genetic risk factors for mold-related illnesses, facilitating accurate diagnosis.
- Personalized Medicine: Understanding the specific biomarkers and genetic predispositions of an individual allows for tailored treatment and prevention strategies, potentially improving outcomes.
- Early Detection: Identifying susceptibility to mold-related illnesses before significant exposure or symptom development can lead to earlier interventions, reducing the impact of these conditions.
By offering a multi-faceted approach to understanding the impact of mold exposure on health, this panel serves as a crucial tool in the management and prevention of mold-related illnesses.